Suivre
sankar navaneethan
sankar navaneethan
Professor of Medicine, Baylor College of Medicine
Adresse e-mail validée de bcm.edu
Titre
Citée par
Citée par
Année
Heart disease and stroke statistics—2020 update: a report from the American Heart Association
SS Virani, A Alonso, EJ Benjamin, MS Bittencourt, CW Callaway, ...
Circulation 141 (9), e139-e596, 2020
14585*2020
Bariatric surgery versus intensive medical therapy for diabetes—5-year outcomes
PR Schauer, DL Bhatt, JP Kirwan, K Wolski, A Aminian, SA Brethauer, ...
New England Journal of Medicine 376 (7), 641-651, 2017
25052017
Bariatric surgery versus intensive medical therapy for diabetes—3-year outcomes
PR Schauer, DL Bhatt, JP Kirwan, K Wolski, SA Brethauer, ...
New England Journal of Medicine 370 (21), 2002-2013, 2014
18632014
Diabetic kidney disease: a report from an ADA Consensus Conference
KR Tuttle, GL Bakris, RW Bilous, JL Chiang, IH De Boer, ...
Diabetes care 37 (10), 2864-2883, 2014
17802014
Heart disease and stroke statistics—2023 update: a report from the American Heart Association
CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson, P Arora, CL Avery, ...
Circulation 147 (8), e93-e621, 2023
11622023
Metabolic syndrome and kidney disease: a systematic review and meta-analysis
G Thomas, AR Sehgal, SR Kashyap, TR Srinivas, JP Kirwan, ...
Clinical journal of the American Society of Nephrology 6 (10), 2364-2373, 2011
6012011
Multinational assessment of accuracy of equations for predicting risk of kidney failure: a meta-analysis
N Tangri, ME Grams, AS Levey, J Coresh, LJ Appel, BC Astor, G Chodick, ...
Jama 315 (2), 164-174, 2016
5562016
KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease
IH de Boer, ML Caramori, JCN Chan, HJL Heerspink, C Hurst, K Khunti, ...
Kidney international 98 (4), S1-S115, 2020
5532020
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
GFM Strippoli, SD Navaneethan, DW Johnson, V Perkovic, F Pellegrini, ...
Bmj 336 (7645), 645-651, 2008
5452008
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
SD Navaneethan, F Pansini, V Perkovic, C Manno, F Pellegrini, ...
The Cochrane database of systematic reviews, CD007784-CD007784, 2009
494*2009
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease
SC Palmer, SD Navaneethan, JC Craig, DW Johnson, M Tonelli, AX Garg, ...
Annals of internal medicine 153 (1), 23-33, 2010
4602010
Weight loss interventions in chronic kidney disease: a systematic review and meta-analysis
SD Navaneethan, H Yehnert, F Moustarah, MJ Schreiber, PR Schauer, ...
Clinical journal of the American Society of Nephrology 4 (10), 1565-1574, 2009
4272009
Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis
SC Palmer, JC Craig, SD Navaneethan, M Tonelli, F Pellegrini, ...
Annals of internal medicine 157 (4), 263-275, 2012
4062012
Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials
P Kandula, M Dobre, JD Schold, MJ Schreiber Jr, R Mehrotra, ...
Clinical Journal of the American Society of Nephrology 6 (1), 50-62, 2011
3902011
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease
GFM Strippoli, C Bonifati, ME Craig, SD Navaneethan, JC Craig, ...
Cochrane Database of Systematic Reviews 2010 (4), 1996
3501996
Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
CM Clase, JJ Carrero, DH Ellison, ME Grams, BR Hemmelgarn, ...
Kidney international 97 (1), 42-61, 2020
3432020
Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis
SD Navaneethan, SU Nigwekar, AR Sehgal, GFM Strippoli
Clinical Journal of the American Society of Nephrology 4 (3), 542-551, 2009
3212009
American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee
CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson, P Arora, CL Avery, ...
Heart disease and stroke statistics-2023 update: a report from the American …, 2023
3092023
Fibroblast growth factor 23 and Inflammation in CKD
JM Mendoza, T Isakova, AC Ricardo, H Xie, SD Navaneethan, ...
Clinical Journal of the American Society of Nephrology 7 (7), 1155-1162, 2012
3082012
Prevalence and correlates of self-reported sexual dysfunction in CKD: a meta-analysis of observational studies
SD Navaneethan, M Vecchio, DW Johnson, V Saglimbene, G Graziano, ...
American Journal of Kidney Diseases 56 (4), 670-685, 2010
2702010
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20